Dr. Pradeep Satya Prasad, MD

Dr. Prasad practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Prasad's NPI, 1639348204, was assigned on February 27, 2008. Dr. Prasad graduated from David Geffen School of Medicine at UCLA in 2005. Dr. Prasad holds California license A99979.

Dr. Prasad's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Prasad's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Prasad is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Prasad to 1 more hospital, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prasad practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Prasad's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Prasad is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Prasad is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, eyelid inflammation, glaucoma, glaucoma surgery, laser destruction of retinal or choroid lesions and retinal detachment among the conditions Dr. Prasad treats.

CMS data shows 4,361 Medicare services from Dr. Prasad across 10 procedure codes in 2024, for 864 Medicare patients. Medicare paid $390,185 for them.

CMS counts 864 Medicare patients who saw Dr. Prasad in 2024. The largest group is 65 to 74, with 357 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Prasad's median patient age at 71, with 54% women.

In 2024, Dr. Prasad wrote 417 Medicare Part D claims for 104 patients. 68% of them were for generic drugs. CMS names the drug for 366 of them, across 10 drugs with 11 or more claims each, at $33,687 in total drug cost. In 2023, CMS named 159 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Prasad for performance year 2024, reported as part of a group. Dr. Prasad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Prasad, published from 2012 to 2025. Dr. Prasad's most frequent co-authors are Hamid Hosseini, David Sarraf, MD and Yamini Attiku, MBBS, MD.

CMS Open Payments shows 214 general payments to Dr. Prasad from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $50,088.

Dr. Prasad graduated from David Geffen School of Medicine at UCLA in 2005. Dr. Prasad is a member of AAO.

Dr. Prasad is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.